Skip to main content
SpringerLink
Log in
Book cover

Hot Topics in Infection and Immunity in Children VI pp 99–119Cite as

Epidemiology and Prevention of Neonatal Candidiasis: Fluconazole for All Neonates?

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 659))

Abstract

The epidemiology and prevention of invasive Candida infections (ICI) depends largely on risk factors and the role they play in infection control and identifying high-risk patients for prevention. Prevention of ICI is critical, as there is significant mortality and even with successful eradication, neurodevelopmental impairment occurs in 57% of survivors weighing less than1000 g (Stoll et al., 2004 Benjamin et al., 2006). It is important to know local invasive fungal infection data in your unit, as the incidence in available literature lacks important key information regarding practices that may increase or decrease the incidence.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aghai, Z.H., Mudduluru, M., Nakhla, T.A., Amendolia, B., Longo, D., Kemble, N., Kaki, S., Sutsko, R., Saslow, J.G., & Stahl, G.E. (2006). Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. J Perinatol, (26), 550–555.

    Article  PubMed  CAS  Google Scholar 

  • Benjamin, D.K., DeLong, E., Cotten, C.M., Garges, H.P., Steinbach, W.J., & Clark, R.H. (2004). Mortality following blood culture in premature infants: increased with gram-negative bacteremia and candidemia, but not gram-positive bacteremia. J Perinatol, (24), 175–180.

    Article  PubMed  Google Scholar 

  • Benjamin, D.K., Jr., DeLong, E.R., Steinbach, W.J., Cotton, C.M., Walsh, T.J., & Clark, R.H. (2003). Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics, (112), 543–547.

    Article  PubMed  Google Scholar 

  • Benjamin, D.K., Jr., Stoll, B.J., Fanaroff, A.A., McDonald, S.A., Oh, W., Higgins, R.D., Duara, S., Poole, K., Laptook, A., & Goldberg, R. (2006). Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics, 117(1), 84–92.

    Article  PubMed  Google Scholar 

  • Bertini, G., Perugi, S., Dani, C., Filippi, L., Pratesi, S., & Rubaltelli, F.F. (2005). Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr, (147), 162–165.

    Article  PubMed  CAS  Google Scholar 

  • Burwell, L.A., Kaufman, D., Blakely, J., Stoll, B.J., & Fridkin, S.K. (2006). Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics, (118), e1019–e1026.

    Article  PubMed  Google Scholar 

  • Clancy, C.J., Staley, B., & Nguyen, M.H. (2006). In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole. Antimicrob Agents Chemother, (50), 3496–3498.

    Article  PubMed  CAS  Google Scholar 

  • Clerihew, L., Austin, N., & McGuire, W. (2007). Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev, CD003850.

    Google Scholar 

  • Clerihew, L., Lamagni, T.L., Brocklehurst, P., & McGuire, W. (2006). Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Arch Dis Child Fetal Neonatal Ed, (91), F188–F192.

    Article  PubMed  CAS  Google Scholar 

  • Clerihew, L. & McGuire, W. (2007). Antifungal prophylaxis for very-low-birth-weight infants: UK national survey. Arch Dis Child Fetal Neonatal Ed, 93(3), F238–F239.

    Article  PubMed  Google Scholar 

  • Cotten, C.M., McDonald, S., Stoll, B., Goldberg, R.N., Poole, K., & BenjaminJr., D.K. (2006). The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics, (118), 717–722.

    Article  PubMed  Google Scholar 

  • El Masry, F.A., Neal, T.J., & Subhedar, N.V. (2002). Risk factors for invasive fungal infection in neonates. Acta Paediatr, (91), 198–202.

    Article  PubMed  CAS  Google Scholar 

  • Ellepola, A.N. & Samaranayake, L.P. (1998). Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents. J Oral Pathol Med, (27), 325–332.

    Article  PubMed  CAS  Google Scholar 

  • Faergemann, J. & Laufen, H. (1993). Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin Exp Dermatol, (18), 102–106.

    Article  PubMed  CAS  Google Scholar 

  • Fairchild, K.D., Tomkoria, S., Sharp, E.C., & Mena, F.V. (2002). Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediatr Infect Dis J, (21), 39–43.

    Article  PubMed  Google Scholar 

  • Feja, K.N., Wu, F., Roberts, K., Loughrey, M., Nesin, M., Larson, E., la-Latta, P., Haas, J., Cimiotti, J., & Saiman, L. (2005). Risk factors for candidemia in critically Ill infants: a matched case-control study. J Pediatr, (147), 156–161.

    Article  PubMed  Google Scholar 

  • Fridkin, S.K., Kaufman, D., Edwards, J.R., Shetty, S., & Horan, T. (2006). Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995–2004. Pediatrics, (117), 1680–1687.

    Article  PubMed  Google Scholar 

  • Ghannoum, M.A., Filler, S.G., Ibrahim, A.S., Fu, Y., & Edwards, J.E., Jr. (1992). Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob Agents Chemother, (36), 2239–2244.

    PubMed  CAS  Google Scholar 

  • Guillet, R., Stoll, B.J., Cotten, C.M., Gantz, M., McDonald, S., Poole, W.K., & Phelps, D.L. (2006). Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics, (117), e137–e142.

    Article  PubMed  Google Scholar 

  • Hack, M. (2006). Neonatology fellowship training in research pertaining to development and follow-up. J Perinatol, 26(Suppl 2), S30–S33.

    Article  PubMed  Google Scholar 

  • Hazen, K.C., Coleman, E., & Wu, G. (2000). Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis of Candida albicans. FEMS Microbiol Lett, (183), 89–94.

    Article  PubMed  CAS  Google Scholar 

  • Healy, C.M., Baker, C.J., Zaccaria, E., & Campbell, J.R. (2005). Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr, (147), 166–171.

    Article  PubMed  CAS  Google Scholar 

  • Healy, C.M., Campbell, J.R., Zaccaria, E., & Baker, C.J. (2008). Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics, (121), 703–710.

    Article  PubMed  Google Scholar 

  • Hof, H. (2008). Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine? Drug Resist Updat, 11(1–2), 25–31.

    Article  PubMed  CAS  Google Scholar 

  • Houang, E.T., Chappatte, O., Byrne, D., Macrae, P.V., & Thorpe, J.E. (1990). Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis. Antimicrob Agents Chemother, (34), 909–910.

    PubMed  CAS  Google Scholar 

  • Hylander, M.A., Strobino, D.M., & Dhanireddy, R. (1998). Human milk feedings and infection among very low birth weight infants. Pediatrics, (102), E38.

    Article  PubMed  CAS  Google Scholar 

  • Johnson, D.E., Thompson, T.R., Green, T.P., & Ferrieri, P. (1984). Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams). Pediatrics, (73), 138–143.

    PubMed  CAS  Google Scholar 

  • Johnsson, H. & Ewald, U. (2004). The rate of candidaemia in preterm infants born at a gestational age of 23–28 weeks is inversely correlated to gestational age. Acta Paediatr, (93), 954–958.

    Article  PubMed  CAS  Google Scholar 

  • Kaufman, D.A. (2008a). Prevention of invasive Candida infections in preterm infants: the time is now. Expert Rev Anti Infect Ther, (6), 393–399.

    Article  PubMed  Google Scholar 

  • Kaufman, D. (2008b). Fluconazole prophylaxis decreases the combined outcome of invasive Candida infections or mortality in preterm infants. Pediatrics, (122), 1158–1159.

    Article  PubMed  Google Scholar 

  • Kaufman, D.A. (2008c). Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU? Curr Opin Pediatr, 20(3), 332–340.

    Article  PubMed  Google Scholar 

  • Kaufman, D., Boyle, R., Hazen, K.C., Patrie, J.T., Robinson, M., & Donowitz, L.G. (2001). Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med, (345), 1660–1666.

    Article  PubMed  CAS  Google Scholar 

  • Kaufman, D., Boyle, R., Hazen, K.C., Patrie, J.T., Robinson, M., & Grossman, L.B. (2005). Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr, (147), 172–179.

    Article  PubMed  CAS  Google Scholar 

  • Kaufman, D., Boyle, R., Robinson, M., & Grossman, L.B. (2003). Long-term safety of intravenous prophylactic fluconazole use in preterm infants less than 1000 grams. Pediatr Res, (53), 484A. Ref Type: Abstract.

    Google Scholar 

  • Kaufman, D.A., Gurka, M.J., Hazen, K.C., Boyle, R., Robinson, M., & Grossman, L.B. (2006). Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth. Pediatr Infect Dis J, (25), 733–737.

    Article  PubMed  Google Scholar 

  • Kaufman, D.A., Manzoni, P., Gurka, M.J., & Grossman, L.B. (2007). Antifungal Prophylaxis in the Neonatal Intensive Care Unit (NICU). Curr Pediatr Rev, 277–288.

    Google Scholar 

  • Kicklighter, S.D., Springer, S.C., Cox, T., Hulsey, T.C., & Turner, R.B. (2001). Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics, (107), 293–298.

    Article  PubMed  CAS  Google Scholar 

  • Kojic, E.M. & Darouiche, R.O. (2004). Candida infections of medical devices. Clin Microbiol Rev, (17), 255–267.

    Article  PubMed  Google Scholar 

  • Koks, C.H., Crommentuyn, K.M., Hoetelmans, R.M., Mathot, R.A., & Beijnen, J.H. (2001). Can fluconazole concentrations in saliva be used for therapeutic drug monitoring? Ther Drug Monit, (23), 449–453.

    Article  PubMed  CAS  Google Scholar 

  • Kramer, M.S., Platt, R.W., Wen, S.W., Joseph, K.S., Allen, A., Abrahamowicz, M., Blondel, B., & Breart, G. (2001). A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics, (108), E35.

    Article  PubMed  CAS  Google Scholar 

  • Leibovitz, E., Iuster-Reicher, A., Amitai, M., & Mogilner, B. (1992). Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis, (14), 485–491.

    PubMed  CAS  Google Scholar 

  • Makhoul, I.R., Bental, Y., Weisbrod, M., Sujov, P., Lusky, A., & Reichman, B. (2007). Candidal versus bacterial late-onset sepsis in very low birthweight infants in Israel: a national survey. J Hosp Infect, (65), 237–243.

    Article  PubMed  Google Scholar 

  • Makhoul, I.R., Sujov, P., Smolkin, T., Lusky, A., & Reichman, B. (2002). Epidemiological, clinical, and microbiological characteristics of late- onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics, (109), 34–39.

    Article  PubMed  Google Scholar 

  • Makhoul, I.R., Sujov, P., Smolkin, T., Lusky, A., & Reichman, B. (2005). Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey. Clin Infect Dis, (40), 218–224.

    Article  PubMed  Google Scholar 

  • Manzoni, P., Arisio, R., Mostert, M., Leonessa, M., Farina, D., Latino, M.A., & Gomirato, G. (2006a). Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics, (117), e22–e32.

    Article  PubMed  Google Scholar 

  • Manzoni, P., Farina, D., Antonielli, D.E., Leonessa, M.L., Gomirato, G., & Arisio, R. (2006b). An association between anatomic site of Candida colonization and risk of invasive candidiasis exists also in preterm neonates in neonatal intensive care unit. Diagn Microbiol Infect Dis, (56), 459–460.

    Article  PubMed  Google Scholar 

  • Manzoni, P., Farina, D., Galletto, P., Leonessa, M., Priolo, C., Arisio, R., & Gomirato, G. (2007a). Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med, (35), 220–226.

    Article  PubMed  Google Scholar 

  • Manzoni, P., Farina, D., Leonessa, M., d’Oulx, E.A., Galletto, P., Mostert, M., Miniero, R., & Gomirato, G. (2006c). Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics, (118), 2359–2364.

    Article  PubMed  Google Scholar 

  • Manzoni, P., Leonessa, M., Galletto, P., Latino, M.A., Arisio, R., Maule, M., Agriesti, G., Gastaldo, L., Gallo, E., Mostert, E., & Farina, D. (2008). Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr Infect Dis J, (27), 731–737.

    Article  PubMed  Google Scholar 

  • Manzoni, P., Mostert, M., Leonessa, M.L., Priolo, C., Farina, D., Monetti, C., Latino, M.A., & Gomirato., G. (2006d). Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis, (42), 1735–1742.

    Article  PubMed  CAS  Google Scholar 

  • Manzoni, P., Stolfi, I., Pugni, L., Decembrino, L., Magnani, C., Vetrano, G., Tridapalli, E., Corona, G., Giovannozzi, C., Farina, D., Arisio, R., Merletti, F., Maule, M., Mosca, F., Pedicino, R., Stronati, M., Mostert, M., & Gomirato, G. (2007b). A multi-center, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med, (356), 2483–2495.

    Article  PubMed  CAS  Google Scholar 

  • Marr, K.A., Seidel, K., Slavin, M.A., Bowden, R.A., Schoch, H.G., Flowers, M.E., Corey, L., & Boeckh, M. (2000b). Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood, (96), 2055–2061.

    PubMed  CAS  Google Scholar 

  • Marr, K.A., Seidel, K., White, T.C., & Bowden, R.A. (2000a). Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis, (181), 309–316.

    Article  PubMed  CAS  Google Scholar 

  • Ozturk, M.A., Gunes, T., Koklu, E., Cetin, N., & Koc, N. (2006). Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. Mycoses, (49), 484–492.

    Article  PubMed  CAS  Google Scholar 

  • O’Grady, M.J. & Dempsey, E.M. (2008). Antifungal prophylaxis for the prevention of neonatal candidiasis? Acta Paediatr, (97), 430–433.

    Article  PubMed  Google Scholar 

  • Pappas, P.G., Rex, J.H., Sobel, J.D., Filler, S.G., Dismukes, W.E., Walsh, T.J., & Edwards, J.E. (2004). Guidelines for treatment of candidiasis. Clin Infect Dis, (38), 161–189.

    Article  PubMed  Google Scholar 

  • Parikh, T.B., Nanavati, R.N., Patankar, C.V., Suman Rao, P.N., Bisure, K., Udani, R.H., & Mehta, P. (2007). Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatr, (44), 830–837.

    PubMed  Google Scholar 

  • Candidiasis. In Pickering, L., Baker, C.J., Long, S.S., & McMillian, J.A., (Eds.) (2006). Red Book. Report of the Committee on Infectious Diseases. (27th ed.). Elk Grove Villiage, IL: American Academy of Pediatrics. pp. 246.

    Google Scholar 

  • Procianoy, R.S., Eneas, M.V., & Silveira, R.C. (2006). Empiric guidelines for treatment of Candida infection in high-risk neonates. Eur J Pediatr, (165), 422–423.

    Article  PubMed  Google Scholar 

  • Saiman, L., Ludington, E., Dawson, J.D., Patterson, J.E., Rangel-Frausto, S., Wiblin, R.T., Blumberg, H.M., Pfaller, M., Rinaldi, M., Edwards, J.E., Wenzel, R.P., & Jarvis, W. (2001). Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J, (20), 1119–1124.

    Article  PubMed  CAS  Google Scholar 

  • Saiman, L., Ludington, E., Pfaller, M., Rangel-Frausto, S., Wiblin, R.T., Dawson, J., Blumberg, H.M., Patterson, J.E., Rinaldi, M., Edwards, J.E., Wenzel, R.P., & Jarvis, W. (2000). Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J, (19), 319–324.

    Article  PubMed  CAS  Google Scholar 

  • Sarvikivi, E., Lyytikainen, O., Soll, D.R., Pujol, C., Pfaller, M.A., Richardson, M., Koukila-Kahkola, P., Luukkainen, P., & Saxen, H. (2005). Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol, (43), 2729–2735.

    Article  PubMed  CAS  Google Scholar 

  • Schuman, P., Capps, L., Peng, G., Vazquez, J., el Sadr, W., Goldman, A.I., Alston, B., Besch, C.L., Vaughn, A., Thompson, M.A., Cobb, M.N., Kerkering, T., & Sobel, J.D. (1997). Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. Ann Intern Med, (126), 689–696.

    PubMed  CAS  Google Scholar 

  • Sims, M.E., Yoo, Y., You, H., Salminen, C., & Walther, F.J. (1988). Prophylactic oral nystatin and fungal infections in very-low- birthweight infants. Am J Perinatol, (5), 33–36.

    Article  PubMed  CAS  Google Scholar 

  • Smith, P.B., Morgan, J., Benjamin, J.D., Fridkin, S.K., Sanza, L.T., Harrison, L.H., Sofair, A.N., Huie-White, S., & Benjamin, D.K., Jr. (2007). Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J, (26), 197–200.

    Article  PubMed  Google Scholar 

  • Sobel, J.D., Wiesenfeld, H.C., Martens, M., Danna, P., Hooton, T.M., Rompalo, A., Sperling, M., Livengood, C., III, Horowitz, B., Von Thron, J., Edwards, L., Panzer, H., & Chu, T.C. (2004). Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med, (351), 876–883.

    Article  PubMed  CAS  Google Scholar 

  • Stoll, B.J., Hansen, N.I., Adams-Chapman, I., Fanaroff, A.A., Hintz, S.R., Vohr, B., & Higgins, R.D. (2004). Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA, (292), 2357–2365.

    Article  PubMed  CAS  Google Scholar 

  • Stoll, B.J., Hansen, N., Fanaroff, A.A., Wright, L.L., Carlo, W.A., Ehrenkranz, R.A., Lemons, J.A., Donovan, E.F., Stark, A.R., Tyson, J.E., Oh, W., Bauer, C.R., Korones, S.B., Shankaran, S., Laptook, A.R., Stevenson, D.K., Papile, L.A., & Poole, W.K. (2002). Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics, (110), 285–291.

    Article  PubMed  Google Scholar 

  • Stoll, B.J., Temprosa, M., Tyson, J.E., Papile, L.A., Wright, L.L., Bauer, C.R., Donovan, E.F., Korones, S.B., Lemons, J.A., Fanaroff, A.A., Stevenson, D.K., Oh, W., Ehrenkranz, R.A., Shankaran, S., & Verter, J. (1999). Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics, (104), e63.

    Article  PubMed  CAS  Google Scholar 

  • Uko, S., Soghier, L.M., Vega, M., Marsh, J., Reinersman, G.T., Herring, L., Dave, V.A., Nafday, S., & Brion, L.P. (2006). Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics, (117), 1243–1252.

    Article  PubMed  Google Scholar 

  • Vaden, S.L., Heit, M.C., Hawkins, E.C., Manaugh, C., & Riviere, J.E. (1997). Fluconazole in cats: pharmacokinetics following intravenous and oral administration and penetration into cerebrospinal fluid, aqueous humour and pulmonary epithelial lining fluid. J Vet Pharmacol Ther, (20), 181–186.

    Article  PubMed  CAS  Google Scholar 

  • Walsh, T.J., Gonzalez, C.E., Piscitelli, S., Bacher, J.D., Peter, J., Torres, R., Shetti, D., Katsov, V., Kligys, K., & Lyman, C.A. (2000). Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. J Clin Microbiol, (38), 2369–2373.

    PubMed  CAS  Google Scholar 

  • Weitkamp, J.H., Ozdas, A., Lafleur, B., & Potts, A.L. (2008). Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. J Perinatol, (286), 405–411.

    Article  Google Scholar 

  • Weitkamp, J.H., Poets, C.F., Sievers, R., Musswessels, E., Groneck, P., Thomas, P., & Bartmann, P. (1998). Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome). Infection, (26), 11–15.

    Article  PubMed  CAS  Google Scholar 

  • White, T.C., Marr, K.A., & Bowden, R.A. (1998). Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, (11), 382–402.

    PubMed  CAS  Google Scholar 

  • Yoder, B.A., Sutton, D.A., Winter, V., & Coalson, J.J. (2004). Resistant Candida parapsilosis associated with long term fluconazole prophylaxis in an animal model. Pediatr Infect Dis J, (23), 687–688.

    Article  PubMed  Google Scholar 

  • Zaoutis, T.E., Heydon, K., Localio, R., Walsh, T.J., & Feudtner, C. (2007). Outcomes attributable to neonatal candidiasis. Clin Infect Dis, (44), 1187–1193.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, University of Virginia Health System, 22908, Charlottesville, VA, USA

    David A. Kaufman

Authors
  1. David A. Kaufman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David A. Kaufman .

Editor information

Editors and Affiliations

  1. Institute of Child Life and Health, University of Bristol, Upper Maudlin Street, Bristol, BS2 8AE, United Kingdom

    Adam Finn

  2. Royal Children's Hosp., University of Melbourne, Parkville , 3052, Australia

    Nigel Curtis

  3. University of Oxford, Level 4,John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom

    Andrew J. Pollard

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kaufman, D.A. (2010). Epidemiology and Prevention of Neonatal Candidiasis: Fluconazole for All Neonates?. In: Finn, A., Curtis, N., Pollard, A. (eds) Hot Topics in Infection and Immunity in Children VI. Advances in Experimental Medicine and Biology, vol 659. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0981-7_9

Download citation

Publish with us

Policies and ethics

Search

Navigation